|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petti S, Masood M and Scully C: The
magnitude of tobacco smoking-betel quid chewing-alcohol drinking
interaction effect on oral cancer in South-East Asia. A
meta-analysis of observational studies. PLoS One. 8:e789992013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tomczak K, Czerwinska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
6
|
Long J, Zhang L, Wan X, Lin J, Bai Y, Xu
W, Xiong J and Zhao H: A four-gene-based prognostic model predicts
overall survival in patients with hepatocellular carcinoma. J Cell
Mol Med. 22:5928–5938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas Research Network, ;
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tibshirani R: The lasso method for
variable selection in the Cox model. Stat Med. 16:385–395. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Yamada S, Wu Y, Wang KY, Liu YP,
Uramoto H, Kohno K and Sasaguri Y: Polypeptide
N-acetylgalactosaminyltransferase-6 expression independently
predicts poor overall survival in patients with lung adenocarcinoma
after curative resection. Oncotarget. 7:54463–54473.
2016.PubMed/NCBI
|
|
11
|
Simon RM, Subramanian J, Li MC and Menezes
S: Using cross-validation to evaluate predictive accuracy of
survival risk classifiers based on high-dimensional data. Brief
Bioinform. 12:203–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu JH, Chang WH, Fu HW, Shu WQ, Yuan T and
Chen P: Upregulated long non-coding RNA LOC90784 promotes cell
proliferation and invasion and is associated with poor clinical
features in HCC. Biochem Biophys Res Commun. 490:920–926. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai M, Chen S, Wei X, Zhu X, Lan F, Dai S
and Qin X: Diagnosis, prognosis and bioinformatics analysis of
lncRNAs in hepatocellular carcinoma. Oncotarget. 8:95799–95809.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niu ZS, Niu XJ and Wang WH: Long
non-coding RNAs in hepatocellular carcinoma: Potential roles and
clinical implications. World J Gastroenterol. 23:5860–5874. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma Y, Luo T, Dong D, Wu X and Wang Y:
Characterization of long non-coding RNAs to reveal potential
prognostic biomarkers in hepatocellular carcinoma. Gene.
663:148–156. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui H, Zhang Y, Zhang Q, Chen W, Zhao H
and Liang J: A comprehensive genome-wide analysis of long noncoding
RNA expression profile in hepatocellular carcinoma. Cancer Med.
6:2932–2941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Wu Q, Feng S, Zhao Y and Tao C:
Identification of four prognostic LncRNAs for survival prediction
of patients with hepatocellular carcinoma. PeerJ. 5:e35752017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
ELife. 4:e050052015. View Article : Google Scholar :
|
|
19
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. Omics. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Friedman J, Hastie T and Tibshirani R:
Regularization paths for generalized linear models via coordinate
descent. J Stat Softw. 33:1–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi H, Yang X, Zhen Y, Huo S, Xiao R and
Xu Z: MicroRNA499 rs3746444 A/G polymorphism functions as a
biomarker to predict recurrence following endoscopic submucosal
dissection in primary early gastric cancer. Mol Med Rep.
15:3245–3251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang W, Hong R, Li L, Wang Y, Du P, Ou Y,
Zhao Z, Liu X, Xiao W, Dong D, et al: The chromosome 11q13.3
amplification associated lymph node metastasis is driven by
miR-548k through modulating tumor microenvironment. Mol Cancer.
17:1252018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu SL, Chen HY, Chang GC, Chen CY, Chen
HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu M, Wang C, Chen W, Mao C and Wang J:
miR-654-5p targets GRAP to promote proliferation, metastasis, and
chemoresistance of oral squamous cell carcinoma through ras/MAPK
signaling. DNA Cell Boil. 37:381–388. 2018. View Article : Google Scholar
|
|
25
|
Wang Y, Xu M and Yang Q: A six-microRNA
signature predicts survival of patients with uterine corpus
endometrial carcinoma. Curr Probl Cancer. 43:167–176. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen YT, Yao JN, Qin YT, Hu K, Wu F and
Fang YY: Biological role and clinical value of miR-99a-5p in head
and neck squamous cell carcinoma (HNSCC): A bioinformatics-based
study. FEBS Open Bio. 8:1280–1298. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niu X, Liu S, Jia L and Chen J: Role of
miR-3619-5p in β-catenin-mediated non-small cell lung cancer growth
and invasion. Cell Physiol Biochem. 37:1527–1536. 2015. View Article : Google Scholar : PubMed/NCBI
|
